Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
US9125937B2 · kind B2 · utility
0Cited by
7References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 19, 2013 |
| Grant date | Sep 8, 2015 |
| Priority date | — |
| Expiry date | Sep 21, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D487/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the compound of formula (I): The present invention also relates to pharmaceutical compositions comprising them and to their use in diagnosis, in particular with SPECT or PET imaging and in therapy of melanoma via targeted radionuclide therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.